LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 117 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | -50.0% | 17,521 | -60.6% | 0.00% | -57.1% |
| Q4 2022 | $52 | -99.5% | 44,442 | +343.2% | 0.01% | +600.0% |
| Q3 2022 | $11,000 | -47.6% | 10,028 | -25.1% | 0.00% | -50.0% |
| Q2 2022 | $21,000 | -86.4% | 13,380 | -75.3% | 0.00% | -86.7% |
| Q2 2021 | $154,000 | +305.3% | 54,131 | +34.3% | 0.02% | +114.3% |
| Q3 2020 | $38,000 | -44.1% | 40,318 | -48.3% | 0.01% | -12.5% |
| Q2 2020 | $68,000 | – | 78,042 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $39,477,000 | 3.01% |
| Raffles Associates | 2,080,536 | $2,351,000 | 2.51% |
| Defender Capital, LLC. | 5,184,035 | $5,862,000 | 2.30% |
| Prescott General Partners LLC | 1,851,851 | $2,093,000 | 0.16% |
| DAFNA Capital Management LLC | 140,000 | $158,000 | 0.04% |
| Fort Sheridan Advisors LLC | 83,931 | $95,000 | 0.03% |
| Long Focus Capital Management, LLC | 215,000 | $243,000 | 0.02% |
| XTX Topco Ltd | 72,807 | $82,000 | 0.02% |
| Ergoteles LLC | 490,895 | $555,000 | 0.02% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $51,000 | 0.02% |